EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction

Narumichi Iwamura, Yuta Matsukuma iD, Eisuke Katafuchi, Yoshiko Nakano, Kanako Tsutsumi, Yuki Ueno, Yasuhisa Tamura, Toshiaki Nakano

CEN Case Reports · 2024

DOI: 10.1007/s13730-024-00933-8 ↗

Kurz gefasst

Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Narumichi Iwamura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan. iwamuran214@gmail.com. Hauptthemen laut MEDLINE: Hypertension, Malignant, Antihypertensive Agents, Acute Kidney Injury, Thrombotic Microangiopathies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant hypertension with renal thrombotic microangiopathy is a rare yet serious cause of acute kidney injury (AKI). Patients are often treated with antihypertensive therapy; however, managing their blood pressure is complex, with targets for initial treatment unclear. We report on a 55-year-old male with severe hypertension (blood pressure 210/140 mmHg), AKI (serum creatinine 9.27 mg/dL), anemia (hemoglobin 7.6 g/dL), thrombocytopenia (platelets 113 k/μL), and renal biopsy confirming malignant arteriolar nephrosclerosis and thrombotic microangiopathy. Previously prescribed 20-mg azilsartan daily, he lost consciousness the next day and was urgently admitted with a blood pressure of 118 mmHg and increased serum creatinine from 1.28 to 9.27 mg/dL over 6 months. Azilsartan was stopped; blood pressure managed with 12.5 mg of losartan daily, targeting systolic pressure between 150 and 160 mmHg. His creatinine peaked on day 14; however, treatment with 12.5 - 50 mg/day of losartan and 5 - 10 mg/day of amlodipine gradually improved renal function to 4.48 mg/dL by month ten without hemodialysis or further syncope. Our case suggests a gradual approach to blood-pressure management to avoid ischemic risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, MalignantAntihypertensive AgentsAcute Kidney InjuryThrombotic MicroangiopathiesHumansMaleMiddle AgedAmlodipineLosartanBlood PressureKidneyCreatinineNephrosclerosisBenzimidazoles

Stichwörter der Autor:innen

Acute kidney injury (AKI)Antihypertensive therapyBlood-pressure managementMalignant hypertensionRenal thrombotic microangiopathy (TMA)

Substanzen

Antihypertensive AgentsAmlodipineLosartanCreatinineBenzimidazoles

Autor:innen und Institutionen

  • Department of Nephrology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan. iwamuran214@gmail.com.
  • Department of Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
  • Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Nephrology, Japan Community Health Care Organization Kyushu Hospital, Kitakyushu, Japan.
  • Department of Nephrology, Steel Memorial Yahata Hospital, Kitakyushu, Japan.

ORCID-Profile: Yuta Matsukuma

Zitieren

APA

Iwamura, N., Matsukuma, Y., Katafuchi, E., Nakano, Y., Tsutsumi, K., Ueno, Y., Tamura, Y., & Nakano, T. (2024). Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction. CEN Case Reports. https://doi.org/10.1007/s13730-024-00933-8

Vancouver

Iwamura N, Matsukuma Y, Katafuchi E, Nakano Y, Tsutsumi K, Ueno Y, et al. Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction. CEN Case Reports. 2024. doi:10.1007/s13730-024-00933-8

BibTeX
@article{Iwamura2024,
  author = {Iwamura, Narumichi and Matsukuma, Yuta and Katafuchi, Eisuke and Nakano, Yoshiko and Tsutsumi, Kanako and Ueno, Yuki and Tamura, Yasuhisa and Nakano, Toshiaki},
  title = {Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction},
  journal = {CEN Case Reports},
  year = {2024},
  doi = {10.1007/s13730-024-00933-8}
}
Kostenlos starten →